C. Crane

发表

Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer.

T. Briere, P. Kelly, P. Das, 2011, International journal of radiation oncology, biology, physics.

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

Jeffrey E. Lee, K. Hess, Douglas B. Evans, 2001, Annals of Surgical Oncology.

Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation.

Douglas B. Evans, E. Abdalla, R. Wolff, 2002, The oncologist.

The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer.

Douglas B. Evans, R. Wolff, P. Pisters, 2006, Best practice & research. Clinical gastroenterology.

A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma

Jeffrey E. Lee, M. Ferrari, A. Maitra, 2018, Clinical Cancer Research.

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

Douglas B. Evans, J. Vauthey, C. Charnsangavej, 2001, International journal of radiation oncology, biology, physics.

Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).

C. Willett, G. Schwartz, B. Minsky, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.

R. Wolff, R. Lenzi, J. Abbruzzese, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancreaticoduodenectomy with vascular resection: margin status and survival duration

Christopher H. Crane, Eddie K. Abdalla, Jeffrey E. Lee, 2004, Journal of Gastrointestinal Surgery.

Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2007, Annals of surgery.

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

Jeffrey E. Lee, J. Vauthey, C. Charnsangavej, 2012, Cancer.

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2014, Journal of Gastrointestinal Surgery.

Management of borderline resectable pancreatic cancer.

M. Katz, G. Varadhachary, C. Crane, 2014, Seminars in radiation oncology.

Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2013, Journal of Gastrointestinal Surgery.

Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer

Mauro Ferrari, Vittorio Cristini, Laurence Court, 2014, Physical biology.

Novel Chemoradiation in Localized Pancreatic Cancer: Clinical Studies

Douglas B. Evans, R. Wolff, P. Pisters, 2006 .

Radiation Dose Considerations in the Palliative Treatment of Locally Advanced Adenocarcinoma of the Pancreas

Douglas B. Evans, R. Wolff, L. Ho, 2005, American journal of clinical oncology.

Incidence and predictors of chest wall toxicity after high-dose radiation therapy in 15 fractions.

Joe Y. Chang, D. Gomez, J. Welsh, 2015, Practical radiation oncology.

Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer.

P. Bhosale, J. Skibber, R. Iyer, 2008, International journal of radiation oncology, biology, physics.

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

A. Khorana, M. Shah, A. Benson, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity.

J. Skibber, S. Kopetz, M. Overman, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes

A. Darzi, N. V. As, S. Laurberg, 2013, The British journal of surgery.

Do We Need Intensity-Modulated Radiation Therapy (IMRT) Routinely in the Preoperative Setting for Rectal Cancer?

P. Das, C. Crane, J. Cox, 2012, Current Colorectal Cancer Reports.

Chapter 24 – The Colon and Rectum

N. Janjan, P. Das, S. Krishnan, 2010 .

Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.

L. Ellis, S. Hamilton, J. Skibber, 2010, International journal of radiation oncology, biology, physics.

Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: how much data do we need?

D. Sargent, C. Crane, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach.

B. Erickson, C. Taniguchi, L. Dawson, 2020, Practical radiation oncology.

Optimization of beam orientations and weights for coplanar conformal beams in treating pancreatic cancer.

I. Rosen, N. Janjan, H. Liu, 1999, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Phase I trial of bevacizumab (BV) with concurrent radiotherapy (RT) and capecitabine (CAP) in locally advanced pancreatic adenocarcinoma (PA)

L. Ellis, R. Wolff, L. Ho, 2005 .

NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases.

M. Schell, C. Willett, L. Dawson, 2019, Practical radiation oncology.

Phase II study of preoperation mFOLFIRINOX and chemoradiation for high-risk resectable and borderline resectable pancreatic adenocarcinoma.

Jeffrey E. Lee, P. Bhosale, Huamin Wang, 2015 .

Future chemoradiation strategies in pancreatic cancer.

Douglas B. Evans, R. Wolff, P. Pisters, 2007, Seminars in oncology.

Preoperative (Neoadjuvant) Therapy for Resectable Adenocarcinoma of the Pancreas

Jeffrey E. Lee, Douglas B. Evans, R. Wolff, 2002 .

Neoadjuvant strategies for pancreatic cancer.

R. Wolff, D. Evans, C. Crane, 2001, Oncology.

Hypofractionated ablative radiation therapy for hepatocellular carcinoma: practical considerations and review of the literature

E. Koay, C. Crane, M. Reyngold, 2018, Hepatoma Research.

Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.

C. Cleeland, T. Mendoza, E. Lin, 2009, International journal of radiation oncology, biology, physics.

Pain and quality of life after treatment in patients with locally recurrent rectal cancer.

A. N. Mirza, S. Curley, C. Cleeland, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of definitive radiation therapy in carcinoma of unknown primary in the abdomen and pelvis.

G. Varadhachary, P. Kelly, P. Das, 2012, International journal of radiation oncology, biology, physics.

Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study.

E. Bruera, L. Bidaut, C. Crane, 2012, Journal of pain and symptom management.

Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?

J. Vauthey, E. Koay, C. Crane, 2017, Hepatobiliary surgery and nutrition.

The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.

J. Fleshman, Anurag K. Singh, H. Thames, 2003, International journal of radiation oncology, biology, physics.

Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

I. Petkovska, M. Gonen, J. Guillem, 2019, JAMA oncology.

Quality of life after intensity-modulated radiation therapy for anal cancer

B. Minsky, P. Das, S. Krishnan, 2015, Journal of Radiation Oncology.

Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer

Jeffrey E. Lee, J. Vauthey, C. Roland, 2015, Annals of Surgical Oncology.

Quality of Life After Intensity Modulated Radiation Therapy (IMRT) for Anal Cancer

B. Minsky, S. Krishnan, M. Delclos, 2013 .

Staging and Therapeutic Approaches for Patients with Localized, Potentially Curable Pancreatic Adenocarcinoma

Douglas B. Evans, R. Wolff, P. Pisters, 2005 .

Multidetector Computed Tomography Follow-up of Hypoattenuating Small Liver Lesions in Patients With Rectal Cancer

Cher Heng Tan, P. Bhosale, R. Iyer, 2011, American journal of clinical oncology.

Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center

M. Weiser, L. Saltz, A. Cercek, 2020, Advances in Radiation Oncology.

Reducing the Morbidity of Rectal Cancer Treatment.

A. Cercek, P. Paty, C. Crane, 2019, JAMA oncology.

Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method.

K. Hoffman, P. Parikh, K. Goodman, 2016, Practical radiation oncology.

Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

M. Gonen, J. Guillem, G. Nash, 2018, JAMA oncology.

In reply [15]

D. Sargent, C. Crane, 2005 .

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer

M. Gonen, J. Guillem, G. Nash, 2022, The oncologist.

Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer

J. Guillem, G. Nash, M. Weiser, 2021, International Journal of Colorectal Disease.

Intensity-modulated radiation therapy (IMRT): Differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.

T. Briere, P. Das, S. Beddar, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma

T. Briere, P. Das, S. Beddar, 2011, Radiation oncology.

Response to preoperative chemoradiation increases the use of sphincter‐preserving surgery in patients with locally advanced low rectal carcinoma

L. Ellis, S. Curley, J. Vauthey, 2003, Cancer.

Radiation Therapy of Resectable Rectal Cancer

M. Ballo, N. Janjan, M. Delclos, 2002 .

Chemoradiation for adenocarcinoma of the anus.

E. Lin, J. Skibber, B. Feig, 2003, International journal of radiation oncology, biology, physics.

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers

J. Niland, A. Benson, K. Goodman, 2017, Advances in radiation oncology.

Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma

Jeffrey E. Lee, A. Maitra, Huamin Wang, 2016, Cancer.

Outcome After Curative Resection for Locally Recurrent Rectal Cancer

L. Ellis, K. Hunt, S. Curley, 2006 .

Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.

Jeffrey S. Morris, S. Hamilton, E. Lin, 2006, International journal of radiation oncology, biology, physics.

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

J. Skibber, C. Crane, 2003, Seminars in surgical oncology.

Chemoradiotherapy for gastrointestinal cancers

Joshua D. Lawson, T. Rich, C. Crane, 2005, Current oncology reports.

Impact of multimodal therapy in locally recurrent rectal cancer

J. Skibber, B. Feig, C. Crane, 2016, The British journal of surgery.

Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: Ten‐year institutional experience

J. Skibber, B. Feig, P. Das, 2014, Journal of surgical oncology.

Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.

M. Talamonti, J. Tward, W. Small, 2011, International journal of radiation oncology, biology, physics.

The role of intraoperative radiotherapy in pancreatic cancer.

Douglas B. Evans, A. Beddar, C. Crane, 2003, Surgical oncology clinics of North America.

The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.

R. Jagsi, J. Ajani, M. Ballo, 2021, Journal of geriatric oncology.

Nonoperative Management of Rectal Cancer Shows Cost-Effectiveness, but Can Comparative Effectiveness Be Established?

C. Crane, Grace L. Smith, P. Romesser, 2020, Journal of the National Cancer Institute.

Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy

J. Skibber, S. Kopetz, R. Wolff, 2017, American journal of clinical oncology.

Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course.

P. Bhosale, J. Skibber, S. Kopetz, 2009, International journal of radiation oncology, biology, physics.

Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer

J. Skibber, B. Feig, R. Wolff, 2007, Cancer.

How Can the Integration of Targeted Agents With Chemoradiation Help Rectal Cancer Patients

C. Crane, 2006 .

Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.

E. Lin, J. Skibber, B. Feig, 2006, International journal of radiation oncology, biology, physics.

Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer.

L. Ellis, H. Sawaf, S. Curley, 2001, International journal of radiation oncology, biology, physics.

Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies.

L. Milas, K. Mason, N. Janjan, 2002, Oncology.

Optimal Management of Gastric Cancer: Results From an International RAND/UCLA Expert Panel

C. Earle, R. McLeod, N. Marcon, 2014, Annals of surgery.

Combined-modality therapy for gastric cancer.

J. Ajani, B. Feig, James C Yao, 2003, Seminars in surgical oncology.

Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus.

T. Kim, K. Goodman, L. Dawson, 2014, Practical radiation oncology.

Palliative and postoperative radiotherapy in biliary tract cancer.

C. Crane, O. Macdonald, 2002, Surgical oncology clinics of North America.

Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone

S. Curley, Douglas B. Evans, I. Wistuba, 2008, Annals of Surgical Oncology.

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated

Douglas B. Evans, J. Vauthey, A. Baschnagel, 2006, Radiation oncology.

P a i n a nd Q uality o f L ife A fter T reatment i n P atients W ith Locally R ecurrent R ectal C ancer

A. N. Mirza, S. Curley, C. Cleeland, 2002 .

RTOG 0822: A Phase II Study of Preoperative (PREOP) Chemoradiotherapy (CRT) Utilizing IMRT in Combination with Capecitabine (C) and Oxaliplatin (O) for Patients with Locally Advanced Rectal Cancer

J. Bendell, T. Hong, F. Lerma, 2011 .

A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer

C. Earle, R. McLeod, N. Marcon, 2013, Annals of Surgical Oncology.

Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.

J. Ajani, Tsung-Teh Wu, B. Feig, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: For some or for all?

C. Crane, K. Narayan, S. Kleid, 1999, Head & neck.

Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second‐stage hepatectomy

J. Vauthey, E. Koay, C. Crane, 2017, Surgery.

Challenges in Reirradiation of Intrahepatic Tumors.

L. Dawson, T. Lawrence, T. Hong, 2020, Seminars in radiation oncology.

Proton Therapy in the Management of Hepatocellular Carcinoma

C. Crane, Haibo Lin, C. Simone, 2022, Cancers.

Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.

J. Vauthey, C. Charnsangavej, R. Wolff, 2001, Seminars in oncology.

Prognostic factors for squamous cell cancer of the anal canal.

J. Ajani, P. Das, C. Crane, 2008, Gastrointestinal cancer research : GCR.

The Promises and Potential Pitfalls of Organ Preservation for Locally Advanced Rectal Cancer

C. Crane, 2006, Annals of Surgical Oncology.

Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer

W. Shi, K. Goodman, M. Lowery, 2017, Acta oncologica.

Stereotactic radiotherapy for pancreatic cancer?

C. Willett, C. Crane, 2009, Cancer.

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

Jeffrey E. Lee, K. Hess, Douglas B. Evans, 2022 .

Proton Therapy in the Management of Luminal Gastrointestinal Cancers: Esophagus, Stomach, and Anorectum

C. Crane, A. Wu, Haibo Lin, 2022, Cancers.

Clinical Investigation : Gastrointestinal Cancer Intensity-Modulated Radiation Therapy With Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma

J. Ajani, A. Beddar, T. Briere, 2012 .

Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.

J. Ajani, N. Janjan, P. Das, 2008, International journal of radiation oncology, biology, physics.

Novel Approaches in Chemoradiation for Localized Pancreas Cancer

C. Crane, 2008 .

Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma.

S. Curley, J. Vauthey, A. Beddar, 2013, Practical radiation oncology.

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.

Jeffrey E. Lee, J. Vauthey, Huamin Wang, 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Is There a Role for Intraoperative Radiation Therapy in Patients with Resected Pancreatic Adenocarcinoma?

Jeffrey Meyer, C. Crane, J. Meyer, 2009, Annals of Surgical Oncology.

Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.

W. Frankel, D. Boffa, K. Goodman, 2017 .

The integration of chemoradiation in the care of patient with localized pancreatic cancer.

R. Wolff, J. Fleming, G. Varadhachary, 2009, Cancer Radiothérapie.

Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation.

N. Sanfilippo, P. Read, T. Rich, 1997, International journal of radiation oncology, biology, physics.

Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

Jeffrey E. Lee, A. Rashid, Huamin Wang, 2012, The American journal of surgical pathology.

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer

E. Holliday, J. Ajani, C. Taniguchi, 2019, Advances in radiation oncology.

Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?

H. Elsaleh, C. Crane, J. Farrell, 2009, Journal of gastroenterology and hepatology.

Transport properties of pancreatic cancer describe gemcitabine delivery and response.

Mauro Ferrari, Vittorio Cristini, Rong Chen, 2014, The Journal of clinical investigation.

Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC

C. Taniguchi, R. Wolff, M. Katz, 2017, Advances in radiation oncology.

T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.

N. Sanfilippo, L. Ellis, S. Curley, 2001, International journal of radiation oncology, biology, physics.

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.

D. Gomez, J. Welsh, Steven H. Lin, 2017, International journal of radiation oncology, biology, physics.

Randomized, Double-Blind, Placebo-Controlled Trial of Epoetin Alfa (Procrit) in Patients with Rectal and Gastric Cancer Undergoing Chemo-Radiotherapy (CT/RT) Followed by Surgery: Early Termination of the Trial Due to Increased Incidence of Thrombo-Embolic Events (TEE).

J. Ajani, S. Hamilton, E. Lin, 2004 .

A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201

A. Benson, S. Alberts, H. Cárdenes, 2008 .

Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer.

B. Erickson, C. Crane, W. Hall, 2021, Surgical oncology clinics of North America.

Recurrence After Resection of Pancreatic Ductal Adenocarcinoma.

K. Goodman, T. Williams, C. Crane, 2020, JAMA surgery.

Ablative Radiotherapy Doses for Locally Advanced: Pancreatic Cancer (LAPC)

C. Crane, E. O’Reilly, 2017, Cancer journal.

Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience

Jeffrey E. Lee, Douglas B. Evans, A. Maitra, 2016, Journal of Gastrointestinal Surgery.

Is Personalization of Care Coming to Pancreatic Oncology?

C. Crane, 2013, Annals of Surgical Oncology.

In reply to Bahl et al.

P. Kelly, C. Crane, 2014, International journal of radiation oncology, biology, physics.

WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment

L. Milas, K. Mason, N. Janjan, 2001, International journal of pancreatology : official journal of the International Association of Pancreatology.

Contemporary perspectives on the use of radiation therapy for locally advanced gallbladder cancer.

C. Crane, V. Verma, 2019, Chinese clinical oncology.

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2010, Annals of Surgical Oncology.

Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality

Jeffrey E. Lee, J. Vauthey, R. Wolff, 2016, Journal of Gastrointestinal Surgery.

Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

Jeffrey E. Lee, E. Abdalla, J. Vauthey, 2012, Annals of Surgical Oncology.

Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus

E. Holliday, C. Taniguchi, B. Minsky, 2017, Clinical and translational radiation oncology.

Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation.

Douglas B. Evans, W. Chan, R. Wolff, 2007, Journal of pain and symptom management.

Initial Experience Combining Cyclooxygenase-2 Inhibition with Chemoradiation for Locally Advanced Pancreatic Cancer

L. Milas, K. Mason, N. Janjan, 2003, American journal of clinical oncology.

Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

J. Vauthey, M. Ballo, R. Wolff, 2001, International journal of gastrointestinal cancer.

Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancer.

J. Skibber, R. Wolff, N. Janjan, 2007, Gastrointestinal cancer research : GCR.

Evaluation of response after chemoradiation for rectal cancer as a predictive factor for the benefit of adjuvant chemotherapy: A pooled analysis of 2,724 individual patients.

C. Capirci, G. Beets, V. Valentini, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Initial Report of Local Control on RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Treated Without Surgery

M. Suntharalingam, A. Raben, A. Dicker, 2014 .

Limitations of conventional doses of chemoradiation for unresectable biliary cancer

S. Curley, J. Vauthey, C. Charnsangavej, 2002 .

E4201: Randomized phase II study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with locally advanced, unresectable, pancreatic cancer (LAPC): Quality-of-life (QOL) analysis.

D. Cella, A. Benson, S. Alberts, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.

W. Jarnagin, C. V. van Eijck, M. Besselink, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Feasibility of ablative stereotactic body radiation therapy of pancreas cancer patients on a 1.5 Tesla magnetic resonance-linac system using abdominal compression

C. Crane, N. Tyagi, K. Tringale, 2021, Physics and imaging in radiation oncology.

Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients

J. Vauthey, E. Koay, K. Raghav, 2017, Cancer.

Impact of preoperative radiation dose escalation on pathologic outcomes and radiation toxicity in locally advanced rectal cancer (LARC): A matched-pair analysis.

J. Skibber, B. Feig, P. Das, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation

J. Skibber, B. Minsky, E. Koay, 2016, American journal of clinical oncology.

Challenges in the Study of Adjuvant Chemoradiation After Pancreaticoduodenectomy

R. Wolff, J. Fleming, G. Varadhachary, 2009, Annals of Surgical Oncology.

Potential Benefits of Integration of Targeted Therapies With Chemoradiation in Rectal Cancer

P. Das, C. Crane, P. Das, 2009 .

A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management

M. Gönen, G. Nash, M. Weiser, 2022, JAMA network open.

Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial

Jeffrey E. Lee, Douglas B. Evans, R. Wolff, 2011, Annals of Surgical Oncology.

Mismatch repair deficient rectal cancer is resistant to induction combination chemotherapy.

K. Goodman, J. Guillem, G. Nash, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

The Added Value of Multidisciplinary Care for Patients with Pancreatic Cancer

Douglas B. Evans, C. Charnsangavej, R. Wolff, 2008, Annals of Surgical Oncology.

Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system

A. Varghese, C. Crane, A. Wu, 2022, Physics and imaging in radiation oncology.

Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer

E. Yorke, A. Jackson, M. Thor, 2021, Advances in radiation oncology.

The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators.

Xiaochun Wang, M. Ballo, A. Beddar, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-dose-rate remote afterloaders for intraoperative radiation therapy.

Song Gao, S. Beddar, M. Delclos, 2007, AORN journal.

Deep-learning-based image registration and automatic segmentation of organs-at-risk in cone-beam CT scans from high-dose radiation treatment of pancreatic cancer.

M. Niethammer, E. Yorke, G. Mageras, 2021, Medical physics.

PROTON THERAPY: IMPROVEMENT IN CLINICALLY RELEVANT DOSES TO SMALL BOWEL IN RECTAL CARCINOMA

P. Das, S. Beddar, C. Crane, 2008 .

The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.

R. Jagsi, J. Ajani, M. Ballo, 2019, Journal of geriatric oncology.

Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.

D. Wigle, T. Dipetrillo, L. Kachnic, 2020 .

Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.

J. Vauthey, M. Ballo, R. Wolff, 2001, International journal of pancreatology : official journal of the International Association of Pancreatology.

Ablative RT Results in Excellent Local Control and Survival in Localized Pancreatic Cancer

E. Yorke, A. Varghese, C. Crane, 2019, International Journal of Radiation Oncology*Biology*Physics.

Limitations of conventional doses of chemoradiation for unresectable biliary cancer.

S. Curley, J. Vauthey, C. Charnsangavej, 2002, International journal of radiation oncology, biology, physics.

Treatment options for anal carcinoma

C. Crane, A. Infantino, L. P. Cerone, 2004 .

Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience

Charles R. Thomas, T. Pawlik, C. Fuller, 2015, Annals of Surgical Oncology.

Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer

Huamin Wang, M. Munsell, R. Wolff, 2016, PloS one.

The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy

Jeffrey E. Lee, J. Vauthey, C. Roland, 2015, Annals of Surgical Oncology.

Elective groin irradiation is not indicated for patients with adenocarcinoma of the rectum extending to the anal canal.

N. Sanfilippo, L. Ellis, J. Vauthey, 2001, International journal of radiation oncology, biology, physics.

Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration.

Jeffrey E. Lee, J. Vauthey, R. Wolff, 2012, Journal of the American College of Surgeons.

Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.

W. Curran, J. Galvin, C. Willett, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation treatment outcomes for unresectable hepatocellular carcinoma

E. Abdalla, J. Vauthey, P. Das, 2011, Acta oncologica.

Liver and Bile Duct Cancer

K. Brown, A. Covey, M. D'Angelica, 2020 .

Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel.

C. Earle, R. McLeod, N. Marcon, 2014, JAMA surgery.

Metastatic Pancreatic Cancer: ASCO Guideline Update.

T. Conroy, P. Philip, M. Shah, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Biomarkers Correlate with Disease-Free Survival in Patients with Anal Canal Carcinoma Treated with Chemoradiation

J. Ajani, A. Rashid, J. Skibber, 2010, Digestive Diseases and Sciences.

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.

M. Zelefsky, J. Reis-Filho, B. Weigelt, 2020, Journal of the National Cancer Institute.

Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.

B. Fisher, J. Michalski, Yuhchyau Chen, 2017, International journal of radiation oncology, biology, physics.

Predictors of Radiotherapy-related GI Toxicity from Anal Cancer DP-IMRT: Secondary Analysis of NRG Oncology RTOG 0529

B. Fisher, J. Michalski, Chang, 2017 .

Occult carcinoma discovered after simple hysterectomy treated with postoperative radiotherapy.

C. Crane, B. Schneider, 1999, International journal of radiation oncology, biology, physics.

Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

Douglas B. Evans, R. Wolff, G. Varadhachary, 2007, Cancer.

Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer

J. Skibber, B. Feig, P. Das, 2010, Annals of Surgical Oncology.

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.

M. Bonnen, J. Vauthey, E. Lin, 2001, International journal of radiation oncology, biology, physics.

Predicting the node negative mesorectum after preoperative chemoradiation (CRT) for locally advanced rectal carcinoma

L. Ellis, K. Hunt, S. Curley, 2003 .

Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial

M. Suntharalingam, A. Raben, A. Dicker, 2017, JAMA oncology.

Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer

R. Wolff, M. Katz, J. Fleming, 2015, Acta oncologica.

Irradiation of recurrent respiratory papillomatosis causing spinal cord compression.

P. Levine, T. Rich, C. Crane, 1999, American journal of otolaryngology.

Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.

Z. Liao, J. Masferrer, L. Milas, 2003, Oncology.

Metformin use and improved response to therapy in rectal cancer

J. Skibber, C. Garrett, P. Kelly, 2013, Cancer medicine.

Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases.

Douglas B. Evans, E. Abdalla, S. Kopetz, 2008, Clinical colorectal cancer.

Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients.

P. Bhosale, T. Briere, P. Das, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chemotherapy for pancreatic cancer.

W. Small, E. Ben-Josef, C. Crane, 2004, The New England journal of medicine.

Number of lymph nodes examined and prognosis among pathologically lymph node‐negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma

J. Skibber, B. Feig, P. Das, 2011, Cancer.

Staging, prognostic factors, and therapy of localized rectal cancer

P. Das, C. Crane, P. Das, 2009, Current oncology reports.

Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer

L. Ellis, L. Levy, J. Skibber, 2006, American journal of clinical oncology.

Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

Sunil Krishnan, Prajnan Das, Christopher H Crane, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chapter 48 – Pancreatic Cancer

R. Abrams, C. Iacobuzio-Donahue, C. Crane, 2016 .

Intraoperative Radiation for Pancreatic Cancer

N. Janjan, C. Crane, 2002 .

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.

D. Wigle, T. Dipetrillo, L. Kachnic, 2022, The Lancet. Oncology.

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.

David Cella, Lynne Wagner, Christopher H Crane, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemotherapy improves outcomes of chemoradiation therapy for locally advanced pancreatic cancer.

R. Wolff, L. Ho, G. Varadhachary, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704

A. Dicker, W. Small, Y. Lawrence, 2018, Cancer.

Neoadjuvant therapy for resectable pancreatic cancer.

Douglas B. Evans, C. Raut, R. Wolff, 2004, Surgical oncology clinics of North America.

Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications

G. Mills, H. Kang, A. Rashid, 2014, PloS one.

Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal Cancer

L. Ellis, S. Curley, J. Vauthey, 2001, American journal of clinical oncology.

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008, Journal of the American College of Surgeons.

Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

Jeffrey E. Lee, Douglas B. Evans, Huamin Wang, 2006, Annals of Surgical Oncology.

Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma.

Jeffrey S. Morris, Jeffrey E. Lee, Douglas B. Evans, 2009, Archives of surgery.

Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study.

C. Earle, R. McLeod, N. Marcon, 2013, Journal of the American College of Surgeons.

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head

R. Abrams, B. Fisher, P. Philip, 2020, American journal of clinical oncology.

Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.

J. Ajani, C. Guha, L. Kachnic, 2017, International journal of radiation oncology, biology, physics.

Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?

H. Thames, R. Wolff, M. Katz, 2017, International journal of radiation oncology, biology, physics.

Long‐term results of weekly/daily cisplatin‐based chemoradiation for locally advanced squamous cell carcinoma of the anal canal

J. Skibber, R. Wolff, P. Das, 2013, Cancer.

Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.

W. Curran, C. Willett, R. Wolff, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer.

E S Paulson, M van Vulpen, B. Erickson, 2017, Practical radiation oncology.

Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survival.

G. Abou-Alfa, J. Harding, C. Crane, 2021, Journal of gastrointestinal oncology.

Local Control and Survival After Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma With Vascular Involvement

M. Gönen, M. D'Angelica, W. Jarnagin, 2021, Annals of surgery.

Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer

Y. Yamada, S. Solomon, J. Erinjeri, 2021, Clinical Cancer Research.

Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer

Jeffrey E. Lee, A. Maitra, P. Bhosale, 2019, JCO precision oncology.

Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions

B. Erickson, P. Parikh, L. Dawson, 2021, Frontiers in Oncology.

A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal.

J. Skibber, R. Wolff, P. Das, 2019, Clinical colorectal cancer.

Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results

Christopher H. Crane, Parag Parikh, P. Parikh, 2019, Radiation Oncology.

Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy

E. Holliday, A. Maitra, C. Taniguchi, 2018, Cancer.

Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases

C. Crane, N. Tyagi, P. Romesser, 2021, Cancers.

External Beam Radiation Therapy for Liver Metastases.

C. Crane, P. Romesser, B. Neal, 2021, Surgical oncology clinics of North America.

Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.

Jeffrey W. Clark, B. Yeap, A. Zhu, 2019, International journal of radiation oncology, biology, physics.

Role of Radiation Therapy in Hepatocellular Carcinoma

E. Holliday, E. Koay, C. Crane, 2018 .

Radiotherapy for Hepatocellular Carcinoma: An Overview

L. Dawson, Y. Akine, J. Seong, 2008, Annals of Surgical Oncology.

Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.

E. Holliday, C. Taniguchi, Sanjay Gupta, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic Body Radiotherapy with Functional Treatment Planning in Hepatocellular Carcinoma

E. Koay, C. Crane, A. Kirichenko, 2017 .

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Lipika Goyal, Christopher H Crane, Edgar Ben-Josef, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Current Approaches and Future Strategies for Pancreatic Carcinoma

Jeffrey E. Lee, Douglas B. Evans, R. Wolff, 2000, Investigational New Drugs.

Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance

Eugene J Koay, Christopher H Crane, E. Koay, 2016, Cancer.

NRG/RTOG 1112: Randomized Phase III Study of Sorafenib vs. Stereotactic Body Radiation Therapy (SBRT) Followed by Sorafenib in Hepatocellular Carcinoma (HCC) (NCT01730937)

L. Dawson, A. Zhu, E. Koay, 2022, International Journal of Radiation Oncology*Biology*Physics.

The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal

J. Vauthey, R. Wolff, P. Das, 2014, Oncotarget.

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

Sunil Krishnan, Jeffrey E. Lee, Douglas B. Evans, 2009, Annals of Surgical Oncology.

BORDERLINE RESECTABLE PANCREATIC CANCER

Douglas B. Evans, R. Wolff, G. Varadhachary, 2014 .

Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.

Douglas B. Evans, R. Wolff, P. Pisters, 2008, International journal of radiation oncology, biology, physics.

Anal Cancer: Background and Clinical Evidence

P. Das, C. Crane, E. Osborne, 2017 .

Long‐term quality of life after radiotherapy for the treatment of anal cancer

A. Baschnagel, S. Cantor, N. Janjan, 2010, Cancer.

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma

Jeffrey E. Lee, J. Vauthey, A. Rashid, 2012, Cancer.

Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta‐analysis

N. Gusani, Nicholas G Zaorsky, C. Crane, 2020, Cancer.

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

A. Khorana, P. Philip, M. Shah, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head.

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head.

Jeffrey E. Lee, Douglas B. Evans, J. Vauthey, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

A. Khorana, P. Philip, M. Shah, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single Nucleotide Polymorphisms of RecQ 1 , RAD 54 L and ATM Genes Are Associated With Reduced Survival of Pancreatic Cancer

K. Hess, Douglas B. Evans, Donghui Li, 2008 .

Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.

K. Hess, Douglas B. Evans, Donghui Li, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation.

J. Skibber, B. Feig, P. Das, 2007, International journal of radiation oncology, biology, physics.

Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer

Jeffrey E. Lee, E. Abdalla, J. Vauthey, 2011, Journal of Gastrointestinal Surgery.

Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2007, Journal of the American College of Surgeons.

Combined-modality treatment for operable pancreatic adenocarcinoma.

Douglas B. Evans, R. Wolff, P. Pisters, 2005, Oncology.

Developments in Chemoradiation for Advanced Pancreatic Cancer

S. Settle, C. Crane, J. Meyer, 2010 .

Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy

S. Faria, C. Raut, R. Wolff, 2006, Abdominal Imaging.

Results of the randomized phase II portion of NRG Oncology/RTOG 0848 evaluating the addition of erlotinib to adjuvant gemcitabine for patients with resected pancreatic head adenocarcinoma.

R. Abrams, B. Fisher, P. Philip, 2017 .

Keys to personalized care in pancreatic oncology.

C. Iacobuzio-Donahue, C. Crane, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma

Jeffrey E. Lee, Douglas B. Evans, D. Bentrem, 2013, Annals of Surgical Oncology.

Cost-effectiveness of Treatment Strategies for Pancreatic Head Adenocarcinoma and Potential Opportunities for Improvement

D. Bentrem, K. Bilimoria, S. Cantor, 2012, Annals of Surgical Oncology.

Pursuit of the Abscopal Effect

C. Crane, P. Romesser, 2020, Digestive Disease Interventions.

Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer

Jeffrey S. Morris, J. Ajani, Tsung-Teh Wu, 2007, Cancer.

Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma

Jeffrey S. Morris, J. Ajani, Tsung-Teh Wu, 2006, Cancer.

Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.

J. Ajani, P. Bhosale, J. Skibber, 2007, International journal of radiation oncology, biology, physics.

Results of Surgical Salvage after Failed Chemoradiation Therapy for Epidermoid Carcinoma of the Anal Canal

J. Skibber, B. Feig, C. Crane, 2004, Annals of Surgical Oncology.

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

Douglas B. Evans, R. Wolff, G. Varadhachary, 2006, Cancer.

Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

Jeffrey E. Lee, R. Wolff, J. Fleming, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer.

E. Yorke, A. Varghese, C. Crane, 2021, JAMA oncology.

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.

J. Ajani, J. Donohue, J. Bradley, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma

P. Brown, I. McCutcheon, C. Crane, 2016, Pituitary.

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

R. Mohan, E. Holliday, Steven H. Lin, 2018, Journal of hepatocellular carcinoma.

Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Anal Cancer: Outcomes and Toxicity

A. Beddar, P. Das, S. Krishnan, 2014, American journal of clinical oncology.

Comparative analysis of volumetric modulated arc therapy versus intensity modulated radiation therapy for radiotherapy of anal carcinoma.

M. Martel, T. Briere, P. Das, 2011, Practical radiation oncology.

Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.

Jeffrey W. Clark, T. Bortfeld, R. Jain, 2018, International journal of radiation oncology, biology, physics.

Long term Outcomes of NRG Oncology/RTOG 0529: A Phase II Evaluation of Dose-Painted Intensity Modulated Radiation Therapy (DP-IMRT) in Combination with 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.

B. Fisher, L. Kachnic, T. Schefter, 2021, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement.

A. Beddar, P. Das, S. Krishnan, 2008, International journal of radiation oncology, biology, physics.

Anal Cancer: Radiation Therapy Planning

P. Das, C. Crane, E. Osborne, 2017 .

Hilar cholangiocarcinoma: expert consensus statement.

J. Vauthey, J. Heimbach, M. Nagino, 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction

J. Ajani, S. Swisher, B. Feig, 2007, Annals of Surgical Oncology.

Impact of Induction Chemotherapy and Preoperative Chemoradiotherapy on Operative Morbidity and Mortality in Patients with Locoregional Adenocarcinoma of the Stomach or Gastroesophageal Junction

J. Ajani, S. Swisher, B. Feig, 2006, Annals of Surgical Oncology.

Long-Term Survival and Recurrence Outcomes Following Surgery for Distal Rectal Cancer

J. Skibber, S. Kopetz, B. Feig, 2010, Annals of Surgical Oncology.

Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short‐term outcomes

M. Gonen, J. Guillem, G. Nash, 2019, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal

A. Rashid, J. Skibber, B. Feig, 2017, American journal of clinical oncology.

Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.

P. Bhosale, H. Thames, T. Hong, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.

S. Maithel, A. El-Khoueiry, T. Bekaii-Saab, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma

E. Holliday, C. Taniguchi, J. Vauthey, 2018, Cancer medicine.

Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer

Christopher H. Crane, C. Crane, 2016, Journal of radiation research.

Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.

K. Hess, J. Ajani, Tsung-Teh Wu, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.

A. Rashid, R. Wolff, P. Das, 2015, The oncologist.

Should cisplatin be avoided in the treatment of locally advanced squamous cell carcinoma of the anal canal?

C. Crane, C. Eng, M. Rodriguez-Bigas, 2009, Nature Clinical Practice Gastroenterology &Hepatology.

Current treatment for localized anal carcinoma

J. Ajani, P. Das, C. Crane, 2007, Current opinion in oncology.

Radiation therapy in operable and locally advanced pancreatic cancer.

A. Ko, C. Crane, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Potential benefits of integration of therapies with chemoradiation in rectal cancer.

P. Das, C. Crane, 2007, Gastrointestinal cancer research : GCR.

RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.

R. Abrams, Donghui Li, W. Regine, 2016, International journal of radiation oncology, biology, physics.

Dose escalation with proton or photon radiation treatment for pancreatic cancer.

T. Briere, S. Beddar, C. Crane, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials

M. Suntharalingam, A. Raben, C. Hallemeier, 2023, JAMA network open.

Preoperative and adjuvant treatment of localized rectal cancer

P. Das, C. Crane, P. Das, 2006, Current oncology reports.

Cisplatin (C) based chemoradiation (CXRT) for locally advanced squamous cell carcinoma (SCCA) of the anal canal (AC): A 20-year perspective.

R. Wolff, P. Das, C. Crane, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results

P. Parikh, C. Crane, M. Reyngold, 2019, Radiation oncology.

Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.

Gabriel O Sawakuchi, Yelin Suh, Sam Beddar, 2016, International journal of radiation oncology, biology, physics.

Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.

R. Mohan, M. Martel, Xiaodong Zhang, 2008, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.

Jeffrey E. Lee, L. Ellis, Douglas B. Evans, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical benefit of palliative radiation therapy in advanced gastric cancer

J. Ajani, N. Janjan, P. Das, 2008, Acta oncologica.

Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres

J. Humm, E. Petre, M. D'Angelica, 2021, Abdominal Radiology.

What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel.

C. Earle, R. McLeod, N. Marcon, 2013, Surgery.

Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumors.

J. Vauthey, P. Das, S. Krishnan, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.

E. Saad, R. Pazdur, J. Skibber, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interstitial Brachytherapy for the Treatment of Locally Recurrent Anorectal Cancer

G. Ibbott, Sanjay Gupta, C. Crane, 2015, Annals of Surgical Oncology.

A High Positive Lymph Node Ratio is Associated with Distant Recurrence after Surgical Resection of Ampullary Carcinoma

Jeffrey E. Lee, J. Vauthey, C. Roland, 2012, Journal of Gastrointestinal Surgery.

Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes.

E. Bruera, M. Spitz, Douglas B. Evans, 2009, Journal of pain and symptom management.

Impact of diabetes and insulin use on prognosis in patients with resected pancreatic cancer: an ancillary analysis of NRG Oncology RTOG 9704.

R. Abrams, A. Benson, C. Fuchs, 2020, International journal of radiation oncology, biology, physics.

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704

R. Abrams, G. Delouya, Yuhchyau Chen, 2018, Advances in radiation oncology.

Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.

R. Abrams, G. Delouya, Yuhchyau Chen, 2019, The oncologist.

NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer.

J. Bendell, T. Hong, S. Jabbour, 2015, International journal of radiation oncology, biology, physics.

WR-2721 Reduces Intestinal Toxicity from Concurrent Gemcitabine and Radiation Treatment.

L. Milas, K. Mason, C. Crane, 2001, International journal of gastrointestinal cancer.

Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence‐free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy

L. Ellis, A. Rashid, J. Skibber, 2013, Cancer.

Radiation therapy for de novo anorectal cancer in patients with a history of prostate radiation therapy

M. Zelefsky, C. Crane, Zhigang Zhang, 2022, Frontiers in Oncology.

Reirradiation to the abdomen for gastrointestinal malignancies

R. Wolff, C. Garrett, P. Das, 2009, Radiation oncology.

Survival and Patterns of Failure in Oligometastatic Esophagogastric Cancer

S. Sihag, D. Gomez, Y. Janjigian, 2020, International Journal of Radiation Oncology, Biology, Physics.

Improving soft-tissue contrast in four-dimensional computed tomography images of liver cancer patients using a deformable image registration method.

Radhe Mohan, Lei Dong, He Wang, 2008, International journal of radiation oncology, biology, physics.

Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines.

T. Kim, L. Dawson, W. Bosch, 2014, International Journal of Radiation Oncology, Biology, Physics.

Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.

R. Abrams, G. Delouya, Yuhchyau Chen, 2020 .

Phase I S tudy o f P reoperative O ral U racil a nd T egafur Plus L eucovorin a nd R adiation T herapy i n R ectal C ancer

E. Saad, R. Pazdur, J. Skibber, 2000 .

Interim results of preoperative gemcitabine (gem) plus cisplatin followed by rapid fractionation chemoradiation for resectable pancreatic adenocarcinoma.

E. Abdalla, R. Wolff, G. Varadhachary, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of Locoregional versus Extended Locoregional Radiation Volumes for Patients with Nonmetastatic Gastro-esophageal Junction Carcinomas

P. Thall, Steven H. Lin, R. Komaki, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Multi-institutional Phase II Trial of Induction Cetuximab Gemcitabine and Oxaliplatin, followed by R

R. Wolff, J. Fleming, G. Varadhachary, 2010 .

Adjuvant chemotherapy in rectal cancer: Defining subgroups who may benefit after neoadjuvant chemoradiation and resection: A pooled analysis of 3,313 patients

C. Capirci, G. Beets, R. Beets-Tan, 2015, International journal of cancer.

Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials

J. Ajani, G. Yothers, L. Kachnic, 2022, American journal of clinical oncology.

Genome-wide host methylation profiling of anal and cervical carcinoma

S. Eschrich, J. Ajani, D. Shibata, 2021, PloS one.

Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum

J. Skibber, B. Minsky, P. Das, 2017, American journal of clinical oncology.

Clinical Investigation : Gastrointestinal Cancer Preoperative Radiation Therapy With Concurrent Capecitabine , Bevacizumab , and Erlotinib for Rectal Cancer : A Phase 1 Trial

J. Skibber, I. Shureiqi, S. Kopetz, 2014 .

Inter- and intrafraction motion assessment and accumulated dose quantification of upper gastrointestinal organs during magnetic resonance-guided ablative radiation therapy of pancreas patients

H. Veeraraghavan, C. Crane, A. Wu, 2022, Physics and imaging in radiation oncology.

Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era.

J. Ajani, R. Komaki, Z. Liao, 2012, International journal of radiation oncology, biology, physics.

The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.

M. Suntharalingam, A. Raben, A. Dicker, 2014 .

Conformal Radiotherapy of the Dominant Liver Metastasis: A Viable Strategy For Treatment of Unresectable Chemotherapy Refractory Colorectal Cancer Liver Metastases

E. Lin, N. Janjan, A. Beddar, 2006, American journal of clinical oncology.

Total neoadjuvant therapy for locally advanced rectal cancer.

J. Guillem, G. Nash, L. Temple, 2017 .

Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head

I. Rosen, Douglas B. Evans, K. Forster, 2001, International journal of gastrointestinal cancer.

Dose Reduction to Small Bowel and Other Relevant Structures in Rectal Carcinoma With Proton Therapy

P. Das, S. Beddar, C. Crane, 2012 .

Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy.

J. Ajani, P. Bhosale, B. Feig, 2008, International journal of radiation oncology, biology, physics.

Outcomes of Patients With Hepatocellular Carcinoma and Advanced Cirrhosis After High-Dose Radiation Therapy Guided by Functional Liver Imaging With Tc99m Sulfur Colloid Liver SPECT-CT

W. Erwin, S. Beddar, C. Crane, 2016 .

Radiotherapy of pancreatic cancer Dose escalation with proton or photon radiation treatment for pancreatic cancer q

T. Briere, S. Beddar, C. Crane, 2009 .

Trials of locoregional therapies inspired by SABR-COMET

D. Sze, T. Vogl, P. Pereira, 2020, The Lancet.

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008, Journal of the American College of Surgeons.

Conformal Radiation Therapy in Pancreatic Cancer

N. Janjan, C. Crane, 2002 .

Borderline resectable pancreatic cancer

Douglas B. Evans, R. Wolff, G. Varadhachary, 2005, Current treatment options in gastroenterology.

Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery

W. Chapman, M. Gönen, P. Parikh, 2021, JAMA network open.

Consensus Report From the Miami Liver Proton Therapy Conference

Tae Hyun Kim, M. Scorsetti, P. Parikh, 2019, Front. Oncol..

Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.

L. Ellis, S. Curley, J. Vauthey, 2000, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.

J. Ajani, A. Beddar, T. Briere, 2012, International journal of radiation oncology, biology, physics.

A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer

J. Skibber, M. Munsell, S. Guha, 2022, Journal of gastrointestinal oncology.

Balancing Fractionation and Advanced Technology in Consideration of Reirradiation.

C. Crane, 2020, Seminars in Radiation Oncology.

Chemo-Re-Irradiation and Salvage Surgery for Locally Recurrent Rectal Cancer

C. Crane, P. Romesser, 2021, Annals of Surgical Oncology.

Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.

Jeffrey W. Clark, B. Yeap, A. Zhu, 2019, International journal of radiation oncology, biology, physics.

Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.

P. Bhosale, H. Thames, T. Hong, 2016, Journal of Clinical Oncology.

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration

J. Vauthey, R. Wolff, P. Pisters, 2001, Annals of Surgical Oncology.

Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study.

E. Bruera, L. Bidaut, C. Crane, 2012, Journal of pain and symptom management.

Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial.

J. Skibber, I. Shureiqi, S. Kopetz, 2014, International journal of radiation oncology, biology, physics.

Preoperative gemcitabine (gem) and bevacizumab (bev)-based chemoradiation for resectable pancreatic adenocarcinoma

Jeffrey E. Lee, Douglas B. Evans, E. Abdalla, 2008 .

Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy.

A. Haynes, J. Vauthey, A. Kambadakone, 2014, Practical radiation oncology.

Temporal patterns of fatigue predict pathological response in patients treated with preoperative chemoradiation therapy for rectal cancer

T. Mendoza, P. Das, M. Delclos, 2011 .

RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.

M. Suntharalingam, A. Raben, A. Dicker, 2014 .

Keys to personalized care in pancreatic oncology.

C. Iacobuzio-Donahue, C. Crane, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors Associated With Premature Ovarian Insufficiency in Young Women With Locally Advanced Rectal Cancer Treated With Pelvic Radiation Therapy

A. Cercek, C. Crane, M. Leitao, 2021, Advances in radiation oncology.

Stereotactic Ablative Radiation Therapy: Role in Treatment of Liver Metastases

R. Timmerman, C. Crane, J. Meyer, 2012, Current Colorectal Cancer Reports.

Phase II trial of neoadjuvant bevacizumab (BEV), capecitabine (CAP), and radiotherapy (XRT) for locally advanced rectal cancer

L. Ellis, J. Skibber, B. Feig, 2008 .

Preoperative and postoperative chemoradiation for locally advanced rectal cancer: sphincter preservation and survival parameters in patients with pathological response to preoperative chemoradiation

M. Ballo, J. Skibber, B. Feig, 2001 .

Updated survival analysis of preoperative gemcitabine (gem) plus bevacizumab (bev)-based chemoradiation for resectable pancreatic adenocarcinoma.

Jeffrey E. Lee, Douglas B. Evans, R. Wolff, 2012 .

Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel.

C. Earle, R. McLeod, N. Marcon, 2014, JAMA surgery.

Preoperative UFT and calcium folinate and radiotherapy in rectal cancer.

R. Pazdur, J. Skibber, N. Janjan, 1999, Oncology.

Neoadjuvant Chemoradiation with Capecitabine Versus Infusional 5-fluorouracil (5-FU) for Locally Advanced Rectal Cancer: A Matched Pair Analysis

E. Lin, J. Skibber, B. Feig, 2005 .

Prospective evaluation of the effect of ionizing radiation on the bladder tumor-associated (BTA) urine test.

M. Clark, D. Theodorescu, C. Crane, 1999, International journal of radiation oncology, biology, physics.

Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality Therapy

A. Vickers, G. Nash, M. Weiser, 2022, Diseases of the colon and rectum.

Perineural and Intraneural Invasion in Posttherapy Pancreaticoduodenectomy Specimens Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

Jeffrey E. Lee, A. Rashid, Huamin Wang, 2012, The American journal of surgical pathology.

Phase I trial of radiotherapy with concurrent bevacizumab, erlotinib, and capecitabine for locally advanced pancreatic cancer (LAPC).

M. Munsell, R. Wolff, J. Fleming, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer.

E. Yorke, K. Goodman, S. Karam, 2023, International journal of radiation oncology, biology, physics.

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases

E. Holliday, C. Taniguchi, J. Vauthey, 2023, Liver Cancer.

Reply to another solution that enables ablative radiotherapy for large liver tumors: Percutaneous interstitial high‐dose rate brachytherapy

E. Koay, C. Crane, 2016, Cancer.

Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy

Jeffrey W. Clark, S. Dima, I. Popescu, 2018, npj Precision Oncology.

A Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: RTOG PA0411

W. Curran, R. Wolff, W. Regine, 2007 .